BioSpace News Archive

Lone Star Bio

Pattern Bioscience Selected as Winner of ADLM Disruptive Technology Award

Pattern Bioscience, Inc. today announced that it was named the winner of the Disruptive Technology Award from the Association for Diagnostics & Laboratory Medicine (ADLM, formerly known as AACC).

July 31, 2023
·
2 min read
Study Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram View

Applying AI to a single apical four chamber (A4C) view echocardiogram provides accurate information to detect heart failure with preserved ejection fraction (HFpEF), according to research published today in JACC Advances.

July 31, 2023
·
5 min read
Bio NC

Labcorp to Host Investor Day on September 14, 2023

Labcorp today announced it will host an Investor Day on Thursday, September 14, 2023 , in New York City , beginning at 1:00 p.m. ET and is expected to conclude by approximately 4:00 p.m. ET.

July 31, 2023
·
1 min read
Business

Eagle Pharmaceuticals Raises 2023 Adjusted non-GAAP EPS¹ Guidance

Eagle Pharmaceuticals, Inc. announced that it has raised its Adjusted non-GAAP earnings per share and Adjusted non-GAAP EBITDA guidance for the 2023 fiscal year.

July 31, 2023
·
9 min read
Business

Castellum Generates Record Quarterly Revenue; Higher Cash Balance

Castellum, Inc. is pleased to announce that its revenue for the second quarter of 2023 was a record.

July 31, 2023
·
3 min read
Business

Protalix BioTherapeutics to Announce Second Quarter 2023 Financial and Business Results on August 7, 2023

Protalix BioTherapeutics, Inc. announced that it will release its financial results for the second quarter ended June 30, 2023 and provide a business update on Monday, August 7, 2023.

July 31, 2023
·
2 min read
Bio NC

RedHill’s RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial and Cleared for Initiation by FDA

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that RHB-107 (upamostat)3 has been accepted for inclusion in the Austere environments Consortium for Enhanced Sepsis Outcomes.

July 31, 2023
·
12 min read
Deals

BioNTech Completes Acquisition of InstaDeep

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the completion of the acquisition of InstaDeep Ltd. (“InstaDeep”), a leading global technology company in the field of artificial intelligence (“AI”) and machine learning (“ML”).

July 31, 2023
·
6 min read
Business

INmune Bio, Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on Monday, August 7

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”) today announced that it will host a conference call on Monday, August 7, 2023 at 4:30 PM Eastern Time to discuss results for its second quarter ended June 30, 2023 and to provide a corporate update.

July 31, 2023
·
3 min read
BioCapital

Gain Therapeutics to Participate in the 2023 BTIG Virtual Biotechnology Conference

Gain Therapeutics, Inc. today announced that members of management will participate in a fireside chat at the 2023 BTIG Virtual Biotechnology Conference on Tuesday, August 8 at 9:30 a.m. ET and host investor meetings.

July 31, 2023
·
1 min read